Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.

MLA

Martino, Massimo, et al. “Long-Term Results in Multiple Myeloma after High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs.” Clinical Lymphoma, Myeloma & Leukemia, vol. 14, no. 2, Apr. 2014, pp. 148–54. EBSCOhost, https://doi.org/10.1016/j.clml.2013.11.009.

APA

Martino, M., Postorino, M., Gallo, G. A., Messina, G., Neri, S., Piro, E., Gentile, M., Moscato, T., Monteleone, R., Fedele, R., Mazzone, C., Console, G., Penna, G., Alati, C., Vincelli, I. D., Irrera, G., Musolino, C., Ronco, F., Molica, S., & Morabito, F. (2014). Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs. Clinical Lymphoma, Myeloma & Leukemia, 14(2), 148–154. https://doi.org/10.1016/j.clml.2013.11.009

Chicago

Martino, Massimo, Maurizio Postorino, Giuseppe Alberto Gallo, Giuseppe Messina, Santo Neri, Eugenio Piro, Massimo Gentile, et al. 2014. “Long-Term Results in Multiple Myeloma after High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs.” Clinical Lymphoma, Myeloma & Leukemia 14 (2): 148–54. doi:10.1016/j.clml.2013.11.009.